Sanofi Consumer Healthcare Q1 net profit surges 36% as export sales jump 144%

Shares of Sanofi Consumer Healthcare India Ltd ended at ₹4,708.10, up by ₹60.65, or 1.31%, on the BSE.

Shares of Sanofi Consumer Healthcare India Ltd ended at ₹4,708.10, up by ₹60.65, or 1.31%, on the BSE.
Ruchit Mehta, Head of Research at SBI Mutual Fund, prefers CDMO and hospital plays within pharma, citing stronger growth prospects over generics. He sees large caps as attractive on valuations, while midcaps require selectivity amid earnings risks. PSU banks may…

AGI Greenpac’s interest cost declined 56% from the previous year, which supported its profitability.

Leela Palaces reported Q4 profit growth of 46% with margin expansion, though shares fell over 4% following the results despite steady operational performance.

Sapphire Foods reported a Q4 loss due to one-time items despite revenue growth and margin expansion, with KFC driving performance even as Pizza Hut India and other income remained weak.

Dalmia Bharat’s EBITDA margins expanded to 20.7% from 19.3% in the year-ago period and were also higher compared to street estimates of 19.5%.

Peak XV was the last remaining PE fund on MobiKwik’s cap table, after the Abu Dhabi Investment Authority had made an exit in September last year.

Gold and silver prices eased in India and globally as investors await US Federal Reserve signals, with geopolitical tensions and inflation worries keeping volatility elevated.

The margin compression was largely due to planned investments in Shipway, which operates at lower margins and weighed on overall profitability.

Paras Defence signs MoU with Complus Systems and JV Micronics to build anechoic chambers in India and abroad, leads consortium, shares rise 0.64% to ₹813.30.